| Jimmy Ching-man Leung, MD | |
|
8020 Constitution Pl Ne, Suite 202, Albuquerque, NM 87110-7607 | |
| (505) 998-3096 | |
| (505) 998-3100 |
| Full Name | Jimmy Ching-man Leung |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 30 Years |
| Location | 8020 Constitution Pl Ne, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750370714 | NPI | - | NPPES |
| 504177 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 28189 (Arizona) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | MD2015-0929 (New Mexico) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Gerald Champion Regional Medical Center | Alamogordo, NM | Hospital |
| Los Alamos Medical Center | Los alamos, NM | Hospital |
| Cibola General Hospital | Grants, NM | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Otero County Hospital Association | 3173516606 | 133 |
| New Mexico Oncology Hematology Consultants Ltd | 3577533447 | 56 |
| X-ray Associates Of New Mexico Pc | 6709879430 | 32 |
News Archive
Myriad Genetics, Inc. today announced that it has signed an agreement to acquire proprietary technology for the diagnosis and prognosis of malignant melanoma using highly validated genetic markers from Melanoma Diagnostics, Inc. of Altadena, California. Under the agreement, Myriad has the right to commercialize all tests derived from the technology on a worldwide basis in exchange for upfront fees and contingent payments based upon the commercial success of the products.
Long-term gene therapy resulted in improved cardiac function and reversed deterioration of the heart in rats with heart failure, according to a recent study conducted by researchers at Thomas Jefferson University's Center for Translational Medicine.
Researchers have devised a tool to accurately assess the extent of symptoms in patients with myeloproliferative neoplasms.
Rheumatoid arthritis (RA) has been associated with increased risk of death in the past, but a new study by investigators from Brigham and Women's Hospital brings that risk into sharper focus. Using data from the Nurses' Health Study, which has followed more than 100,000 female registered nurses since 1976, researchers found that rheumatoid arthritis significantly increased participants' overall risk of death, especially risk of death due to respiratory or cardiovascular causes.
› Verified 7 days ago
| Entity Name | X-ray Associates Of New Mexico Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235105800 PECOS PAC ID: 6709879430 Enrollment ID: O20040407000573 |
News Archive
Myriad Genetics, Inc. today announced that it has signed an agreement to acquire proprietary technology for the diagnosis and prognosis of malignant melanoma using highly validated genetic markers from Melanoma Diagnostics, Inc. of Altadena, California. Under the agreement, Myriad has the right to commercialize all tests derived from the technology on a worldwide basis in exchange for upfront fees and contingent payments based upon the commercial success of the products.
Long-term gene therapy resulted in improved cardiac function and reversed deterioration of the heart in rats with heart failure, according to a recent study conducted by researchers at Thomas Jefferson University's Center for Translational Medicine.
Researchers have devised a tool to accurately assess the extent of symptoms in patients with myeloproliferative neoplasms.
Rheumatoid arthritis (RA) has been associated with increased risk of death in the past, but a new study by investigators from Brigham and Women's Hospital brings that risk into sharper focus. Using data from the Nurses' Health Study, which has followed more than 100,000 female registered nurses since 1976, researchers found that rheumatoid arthritis significantly increased participants' overall risk of death, especially risk of death due to respiratory or cardiovascular causes.
› Verified 7 days ago
| Entity Name | New Mexico Oncology Hematology Consultants Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164475232 PECOS PAC ID: 3577533447 Enrollment ID: O20040728000867 |
News Archive
Myriad Genetics, Inc. today announced that it has signed an agreement to acquire proprietary technology for the diagnosis and prognosis of malignant melanoma using highly validated genetic markers from Melanoma Diagnostics, Inc. of Altadena, California. Under the agreement, Myriad has the right to commercialize all tests derived from the technology on a worldwide basis in exchange for upfront fees and contingent payments based upon the commercial success of the products.
Long-term gene therapy resulted in improved cardiac function and reversed deterioration of the heart in rats with heart failure, according to a recent study conducted by researchers at Thomas Jefferson University's Center for Translational Medicine.
Researchers have devised a tool to accurately assess the extent of symptoms in patients with myeloproliferative neoplasms.
Rheumatoid arthritis (RA) has been associated with increased risk of death in the past, but a new study by investigators from Brigham and Women's Hospital brings that risk into sharper focus. Using data from the Nurses' Health Study, which has followed more than 100,000 female registered nurses since 1976, researchers found that rheumatoid arthritis significantly increased participants' overall risk of death, especially risk of death due to respiratory or cardiovascular causes.
› Verified 7 days ago
| Entity Name | Otero County Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861450579 PECOS PAC ID: 3173516606 Enrollment ID: O20070212000377 |
News Archive
Myriad Genetics, Inc. today announced that it has signed an agreement to acquire proprietary technology for the diagnosis and prognosis of malignant melanoma using highly validated genetic markers from Melanoma Diagnostics, Inc. of Altadena, California. Under the agreement, Myriad has the right to commercialize all tests derived from the technology on a worldwide basis in exchange for upfront fees and contingent payments based upon the commercial success of the products.
Long-term gene therapy resulted in improved cardiac function and reversed deterioration of the heart in rats with heart failure, according to a recent study conducted by researchers at Thomas Jefferson University's Center for Translational Medicine.
Researchers have devised a tool to accurately assess the extent of symptoms in patients with myeloproliferative neoplasms.
Rheumatoid arthritis (RA) has been associated with increased risk of death in the past, but a new study by investigators from Brigham and Women's Hospital brings that risk into sharper focus. Using data from the Nurses' Health Study, which has followed more than 100,000 female registered nurses since 1976, researchers found that rheumatoid arthritis significantly increased participants' overall risk of death, especially risk of death due to respiratory or cardiovascular causes.
› Verified 7 days ago
| Entity Name | Knd Development 59 Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215266754 PECOS PAC ID: 3678602802 Enrollment ID: O20101202000819 |
News Archive
Myriad Genetics, Inc. today announced that it has signed an agreement to acquire proprietary technology for the diagnosis and prognosis of malignant melanoma using highly validated genetic markers from Melanoma Diagnostics, Inc. of Altadena, California. Under the agreement, Myriad has the right to commercialize all tests derived from the technology on a worldwide basis in exchange for upfront fees and contingent payments based upon the commercial success of the products.
Long-term gene therapy resulted in improved cardiac function and reversed deterioration of the heart in rats with heart failure, according to a recent study conducted by researchers at Thomas Jefferson University's Center for Translational Medicine.
Researchers have devised a tool to accurately assess the extent of symptoms in patients with myeloproliferative neoplasms.
Rheumatoid arthritis (RA) has been associated with increased risk of death in the past, but a new study by investigators from Brigham and Women's Hospital brings that risk into sharper focus. Using data from the Nurses' Health Study, which has followed more than 100,000 female registered nurses since 1976, researchers found that rheumatoid arthritis significantly increased participants' overall risk of death, especially risk of death due to respiratory or cardiovascular causes.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jimmy Ching-man Leung, MD 8020 Constitution Pl Ne, Suite 202, Albuquerque, NM 87110-7607 Ph: (505) 998-3096 | Jimmy Ching-man Leung, MD 8020 Constitution Pl Ne, Suite 202, Albuquerque, NM 87110-7607 Ph: (505) 998-3096 |
News Archive
Myriad Genetics, Inc. today announced that it has signed an agreement to acquire proprietary technology for the diagnosis and prognosis of malignant melanoma using highly validated genetic markers from Melanoma Diagnostics, Inc. of Altadena, California. Under the agreement, Myriad has the right to commercialize all tests derived from the technology on a worldwide basis in exchange for upfront fees and contingent payments based upon the commercial success of the products.
Long-term gene therapy resulted in improved cardiac function and reversed deterioration of the heart in rats with heart failure, according to a recent study conducted by researchers at Thomas Jefferson University's Center for Translational Medicine.
Researchers have devised a tool to accurately assess the extent of symptoms in patients with myeloproliferative neoplasms.
Rheumatoid arthritis (RA) has been associated with increased risk of death in the past, but a new study by investigators from Brigham and Women's Hospital brings that risk into sharper focus. Using data from the Nurses' Health Study, which has followed more than 100,000 female registered nurses since 1976, researchers found that rheumatoid arthritis significantly increased participants' overall risk of death, especially risk of death due to respiratory or cardiovascular causes.
› Verified 7 days ago
Mark Ehrhart, MD Radiology Medicare: Medicare Enrolled Practice Location: Msc 10 5550, 1 University Of New Mexico, Albuquerque, NM 87131 Phone: 505-272-4661 | |
Dr. Shaya Ansari, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 8020 Constitution Pl Ne Ste 202, Albuquerque, NM 87110 Phone: 505-998-3096 Fax: 505-998-3100 | |
Dr. Karen Renee Craig, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2211 Lomas Blvd Ne, Albuquerque, NM 87106 Phone: 505-272-0011 | |
Erika Jane Starks, MD, PHD Radiology Medicare: Medicare Enrolled Practice Location: Radiology Msc 10-5530 1 University Of New Mexico, Albuquerque, NM 87131 Phone: 505-272-6225 | |
Stuart Bernard Paster, Radiology Medicare: Not Enrolled in Medicare Practice Location: 8020 Constitution Place Ne, #101, Albuquerque, NM 87110 Phone: 505-998-1317 Fax: 505-998-1308 | |
Danielle Eckart Sorte, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: Dept Of Radiology Msc 10 5530, 1 University Of New Mexico, Albuquerque, NM 87131 Phone: 801-641-5515 | |
Dr. Luis Centenera, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4411 The 25 Way Ne, Suite 150, Albuquerque, NM 87109 Phone: 505-332-5800 Fax: 505-332-6919 |